| Document Date: 2009-03-31 14:44:43
Open Document File Size: 504,10 KBShare Result on Facebook
Company Nordic BMT Group / / Event FDA Phase / / Facility Laboratory Tests / / IndustryTerm therapy for chronic myelogenous leukemia / aqueous media / / MedicalCondition Bronchopulmonary dysplasia / Cardiac tamponade / hepatic venoocclusive disease / lymphoma / Seizures / myelodysplastic syndrome / blast crisis / sterility / chronic busulfan therapy / nausea / stomatitis / thrombocytopenia / pulmonary fibrosis / hepatic veno-occlusive disease / second malignancy / chronic / low-dose busulfan therapy / capillary leak syndrome / lymphopenia / head trauma / hypersensitivity / thalassemia / systemic infection / bronchogenic carcinoma / leukemia / Abdominal pain / severe pancytopenia / pneumonia / busulfan produced sterility / cancer / disease / acute leukemia / TBI / chronic / azoospermia and testicular atrophy / host disease / progressive disease / neutropenia / Severe granulocytopenia / seizure disorder / hematologic malignancies / thymic and ovarian tumors / acute lymphoblastic leukemia / seizure / vomiting / cleft palate / diseases / chronic myelogenous leukemia / HVOD / veno-occlusive disease / acute myelogenous leukemia / anemia / / MedicalTreatment radiation therapy / red blood cell transfusions / platelet transfusions / chemotherapy / intravenous infusion / radiation / platelet transfusion / total body irradiation / Antibiotic therapy / adjuvant therapy / / Position qualified physician / / Product granisetron / acetaminophen / Itraconazole / Sodium Chloride / cyclophosphamide / Polyethylene Glycol / Dextrose / BUSULFEX / Kytril / Fluconazole / CL / phenytoin / Zofran / etoposide / BUSULFEX (busulfan) Injection / / Technology radiation / transplantation / Pharmacokinetics / chemotherapy / /
SocialTag |
BUSULFEX® (busulfan) Injection Caution: Must be diluted prior to use.